New eye injection trial aims to control Vision-Threatening swelling
NCT ID NCT06825702
Summary
This study is testing an experimental eye injection called KIO-104 for people with macular edema, a condition where fluid builds up in the central part of the retina and can blur vision. Researchers are enrolling 28 adults to receive injections every 2 or 4 weeks to see if the treatment is safe and if it can reduce the swelling. The main goal is to find the right dose and schedule that controls the condition with minimal side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Eye Research Australia
RECRUITINGEast Melbourne, Victoria, 3002, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lions Eye Institute Limited
RECRUITINGNedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Royal Adelaide Hospital
NOT_YET_RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sydney Eye Hospital
RECRUITINGSydney, New South Wales, 2001, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.